Protagonist Therapeutics (PTGX) announced topline results from ANTHEM-UC, a Phase 2b study of icotrokinra, the first investigational targeted ...
The eight-week, quadruple-masked, dose-finding, core stage of the Phase 2b clinical trial is evaluating the efficacy and ...
Explore SGMT's breakthrough MASH therapy, Denifanstat, with FDA designation & Phase 3 progress. Click here to read my most ...
REHOVOT, Israel, March 10, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: ...
"The SGR is a transformative project for Kisumu and the entire western Kenya region. This extension will bring much-needed ...
Topline Results for Phase 2b PROGRESS Study of Pilavapadin (LX9211) in Diabetic Peripheral Neuropathic Pain (DPNP); 10 mg dose to Advance into ...
Investor Conferences. VYNE will be participating in the upcoming Leerink Partners Global Healthcare Conference, taking place in Miami from March 10-12, 2025, as well as the H.C. Wainwright 3rd Annual ...
Clinical Trials Arena on MSN3d
Beckley Psytech completes subjects’ enrolment for Phase IIb trial of TRD therapyBeckley Psytech has completed subject enrolment for the core stage of the global Phase IIb clinical trial of patent-protected ...
Chronic spontaneous urticaria is an idiopathic syndrome defined by recurring itch, hives, or angioedema (or a combination of ...
Alto Neuroscience, Inc.’s ANRO share price has dipped by 10.13%, which has investors questioning if this is right time to buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback